24.75 USD
+0.4 (+1.64%)
Taking everything into account, PTHS scores 0 out of 10 in our fundamental rating. PTHS was compared to 525 industry peers in the Biotechnology industry. Both the profitability and financial health of PTHS have multiple concerns. PTHS does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- PTHS had negative earnings in each of the past 5 years.
- PTHS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- PTHS has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PTHS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, PTHS has more shares outstanding
- PTHS has a better debt/assets ratio than last year.
2.2 Solvency
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for PTHS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PELTHOS THERAPEUTICS INC / PTHS FAQ
What is the ChartMill fundamental rating of PELTHOS THERAPEUTICS INC (PTHS) stock?
ChartMill assigns a fundamental rating of 0 / 10 to PTHS.
What is the valuation status of PELTHOS THERAPEUTICS INC (PTHS) stock?
ChartMill assigns a valuation rating of 0 / 10 to PELTHOS THERAPEUTICS INC (PTHS). This can be considered as Overvalued.
How profitable is PELTHOS THERAPEUTICS INC (PTHS) stock?
PELTHOS THERAPEUTICS INC (PTHS) has a profitability rating of 0 / 10.
What is the financial health of PELTHOS THERAPEUTICS INC (PTHS) stock?
The financial health rating of PELTHOS THERAPEUTICS INC (PTHS) is 0 / 10.